Dudediligence.

Monopar Therapeutics Inc

MNPRNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$1.3MSep ’24−$10.9MDec ’24−$2.6MMar ’25−$2.5MJun ’25−$3.4MSep ’25−$5.2MDec ’25−$3.9MMar ’26−$5.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on filenone on file$0.00$0.00
Operating income−$9.1M−$10.5M−$8.8M−$16.2M−$16.7M
Net income−$9.1M−$10.5M−$8.4M−$15.6M−$13.7M
Operating cash flow−$7.3M−$7.2M−$7.9M−$6.4M−$12.2M
Cash$20.3M$8.2M$7.3M$45.8M$61.8M
Shares outstanding12.6M12.9M3.0M6.1M6.7M